- Source: Lys-MDMA
Lys-MDMA, or lysine-MDMA, also known as N-(L-lysinamidyl)-MDMA, is a prodrug of MDMA which is being investigated for possible use as a pharmaceutical drug in the treatment of psychiatric disorders. Structurally, lys-MDMA is to MDMA as lisdexamfetamine is to dextroamphetamine As of August 2024, a phase 1 clinical trial comparing MDMA, MDA, lys-MDMA, and lys-MDA has been conducted and completed. Lys-MDMA is being developed by MindMed.
See also
Lys-MDA
Lisdexamfetamine
DA-Phen
Phenatine
References
External links
Lysine-MDMA - Isomer Design
Kata Kunci Pencarian:
- Lys-MDMA
- Lys-MDA
- Empathogen
- N-t-BOC-MDMA
- List of investigational hallucinogens and entactogens
- 5-MAPB
- 5-MAPBT
- MDAI
- Substituted methylenedioxyphenethylamine
- Α-Ethyltryptamine
